SynCore Biotechnology Co (ROCO:4192) ROCE %: -19.62% (As of Dec. 2025)


ROCO:4192 SynCore Biotechnology Co Ltd ROCO:4192
67 GF Score
Price NT$20.00
GF Value NT$47.67
Valuation Possible Value Trap
! 1 Warning Sign
View Full Analysis

What is SynCore Biotechnology Co ROCE %?

SynCore Biotechnology Co ROCO:4192 -2.44% 67 ROCE % is -19.62% as of Dec. 2025. GuruFocus rates ROCO:4192 with a GF Score™ of 67/100 and a GF Value™ of NT$47.67 (Possible Value Trap). The stock has 1 warning sign investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. SynCore Biotechnology Co's annualized ROCE % for the quarter that ended in Dec. 2025 was -19.62%.

SynCore Biotechnology Co  (ROCO:4192) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

SynCore Biotechnology Co ROCE % Related Terms

SynCore Biotechnology Co ROCE % Historical Data

* Premium members only.

The historical data trend for SynCore Biotechnology Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

SynCore Biotechnology Co ROCE % Chart

SynCore Biotechnology Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -90.52 -53.80 -12.32 -16.54 -16.84

SynCore Biotechnology Co Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -17.00 -18.91 -17.04 -12.21 -19.62
ROCO:4192
67GF Score
SynCore Biotechnology Co Ltd ROCO:4192
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

SynCore Biotechnology Co ROCE % Calculation

SynCore Biotechnology Co's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=-45.582/( ( (317.801 - 22.122) + (255.702 - 10.074) )/ 2 )
=-45.582/( (295.679+245.628)/ 2 )
=-45.582/270.6535
=-16.84 %

SynCore Biotechnology Co's ROCE % of for the quarter that ended in Dec. 2025 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Dec. 2025 )  (Q: Sep. 2025 )(Q: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Dec. 2025 )  (Q: Sep. 2025 )(Q: Dec. 2025 )
=-49.396/( ( (272.851 - 14.879) + (255.702 - 10.074) )/ 2 )
=-49.396/( ( 257.972 + 245.628 )/ 2 )
=-49.396/251.8
=-19.62 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2025) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of -19.62% mean?
SynCore Biotechnology Co (ROCO:4192) has a ROCE % of -19.62% as of Dec. 2025.
Is SynCore Biotechnology Co's ROCE % too high?
SynCore Biotechnology Co's current ROCE % is -19.62%. Overall, SynCore Biotechnology Co has a GF Score™ of 67/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does SynCore Biotechnology Co's ROCE % compare to VRTX and REGN?
SynCore Biotechnology Co's ROCE % of -19.62% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Biotechnology company?
A good ROCE % depends on the Biotechnology industry context. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. SynCore Biotechnology Co's current ROCE % is -19.62%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SynCore Biotechnology Co stock overvalued right now?
Based on GuruFocus' analysis, SynCore Biotechnology Co (ROCO:4192) is currently considered Possible Value Trap. The stock's GF Value™ is NT$47.67, compared to a current price of NT$20.00 — trading 58% below its estimated fair value. The current ROCE % is -19.62%. SynCore Biotechnology Co's overall GF Score™ is 67/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For SynCore Biotechnology Co (ROCO:4192), the current ROCE % is -19.62% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is SynCore Biotechnology Co (ROCO:4192) Overvalued in 2026?

Based on GuruFocus' analysis, SynCore Biotechnology Co stock appears to be undervalued. The current stock price of NT$20.00 is trading 58% below its estimated GF Value™ of NT$47.67. GuruFocus considers SynCore Biotechnology Co to be Possible Value Trap.

Key valuation signals for ROCO:4192:

  • ROCE %: -19.62%
  • GF Value™: NT$47.67 vs. price of NT$20.00 (58% below fair value)
  • GF Score™: 67/100 with 1 warning sign

No single metric tells the full story. See the ROCO:4192 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

SynCore Biotechnology Co Business Description

Address No. 84 Zhongshan Road, Zhongshan Village, Dongshan Township, Yilan, TWN, 269
SynCore Biotechnology Co Ltd is a biotechnology company. The pipeline products of the company include SB01 and 02, SB03, SB04, SB05, and Others. It is engaged in new drug development and sales, healthy food development and sales, medicine inspection, biotechnology services, and intellectual property. It operates in a single industry, the new drug development. The company generates the majority of its revenue from medical products and healthy food.
67GF Score

Get the complete analysis for ROCO:4192

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$20.00
Price
NT$47.67
GF Value